Time-resolved proteomic and phosphoproteomic analysis reveals convergent and divergent biological perturbations induced by FDA-approved CDK4/6 inhibitors in hormone receptor-positive breast cancers

Name: Time-resolved proteomic and phosphoproteomic analysis reveals convergent and divergent biological perturbations induced by FDA-approved CDK4/6 inhibitors in hormone receptor-positive breast cancers
Creator: Shanghai Institute of Materia Medica
Published: 2026-01-07T17:10:31+08:00

integrated proteome resources2026-06-12 收录

癌症靶向治疗

蛋白质组学分析

数据链接：

https://www.iprox.cn/page/project.html?id=IPX0015026000 数据链接链接失效反馈

官方服务：

资源简介：

Time-resolved proteomic and phosphoproteomic analysis reveals convergent and divergent biological perturbations induced by FDA-approved CDK4/6 inhibitors in hormone receptor-positive breast cancers

提供机构：

Shanghai Institute of Materia Medica

创建时间：

2026-01-07